Ligand Pharmaceuticals Inc (NASDAQ:LGND)

130.47
BATS BZX Real-Time Price
As of Oct 15
 0.00 / 0.00%
Today’s Change
78.26
Today|||52-Week Range
219.75
+31.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego California 92121
P:(858) 550-7500
Investor Relations:
(858) 550-7768

Employees

Shareholders

Mutual fund holders61.10%
Other institutional37.74%
Individual stakeholders30.78%

Top Executives

John L. HigginsChief Executive Officer & Director
Matthew William FoehrPresident & Chief Operating Officer
Matthew Edward KorenbergChief Financial Officer & Executive VP-Finance
Eric VajdaVice President-Preclinical Research & Development
Charles Stuart BerkmanSecretary, Senior Vice President & General Counsel